Symbol:
Naa15
Name:
N(alpha)-acetyltransferase 15, NatA auxiliary subunit
RGD ID:
1310984
Description:
Predicted to enable N-acetyltransferase activity and acetyltransferase activator activity. Predicted to contribute to acetyltransferase activity and ribosome binding activity. Predicted to be involved in several processes, including N-terminal protein amino acid acetylation; positive regulation of DNA-templated transcription; and protein stabilization. Predicted to be located in cytosol and nuclear body. Predicted to be part of NatA complex and transcription regulator complex. Predicted to be active in cytoplasm. Human ortholog(s) of this gene implicated in autosomal dominant intellectual developmental disorder 50. Orthologous to human NAA15 (N-alpha-acetyltransferase 15, NatA auxiliary subunit); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,4-dinitrotoluene; 2,6-dinitrotoluene.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
LOC310399; N-alpha-acetyltransferase 15, NatA auxiliary subunit; Narg1; NMDA receptor regulated 1; NMDA receptor-regulated gene 1
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
NAA15 (N-alpha-acetyltransferase 15, NatA auxiliary subunit)
HGNC
HomoloGene, NCBI, Panther
Mus musculus (house mouse):
Naa15 (N(alpha)-acetyltransferase 15, NatA auxiliary subunit)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Naa15 (N-alpha-acetyltransferase 15, NatA auxiliary subunit)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
NAA15 (N-alpha-acetyltransferase 15, NatA auxiliary subunit)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
NAA15 (N-alpha-acetyltransferase 15, NatA auxiliary subunit)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Naa15 (N-alpha-acetyltransferase 15, NatA auxiliary subunit)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
NAA15 (N-alpha-acetyltransferase 15, NatA auxiliary subunit)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
NAA15 (N-alpha-acetyltransferase 15, NatA auxiliary subunit)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Naa15 (N-alpha-acetyltransferase 15, NatA auxiliary subunit)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
NAA16 (N-alpha-acetyltransferase 16, NatA auxiliary subunit)
HGNC
OrthoDB
Alliance orthologs 3
Mus musculus (house mouse):
Naa15 (N(alpha)-acetyltransferase 15, NatA auxiliary subunit)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
NAA15 (N-alpha-acetyltransferase 15, NatA auxiliary subunit)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
naa15a (N(alpha)-acetyltransferase 15, NatA auxiliary subunit a)
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER|PhylomeDB)
Danio rerio (zebrafish):
naa15b (N(alpha)-acetyltransferase 15, NatA auxiliary subunit b)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
NAT1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
Naa15-16
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
hpo-29
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
naa15
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 2 137,608,883 - 137,671,618 (+) NCBI GRCr8 mRatBN7.2 2 135,458,018 - 135,520,756 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 2 135,457,948 - 135,520,756 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 2 142,033,903 - 142,096,632 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 2 140,146,168 - 140,208,898 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 2 134,777,618 - 134,840,821 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 2 140,471,437 - 140,534,259 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 140,471,690 - 140,534,259 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 2 159,946,628 - 160,009,197 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 2 140,308,955 - 140,371,869 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 2 140,258,958 - 140,319,864 (+) NCBI Celera 2 129,953,617 - 130,016,267 (+) NCBI Celera Cytogenetic Map 2 q26 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Naa15 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO NAA15 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NAA15 mRNA CTD PMID:22079256 Naa15 Rat 1,2-dimethylhydrazine multiple interactions ISO Naa15 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of NAA15 mRNA CTD PMID:22206623 Naa15 Rat 17alpha-ethynylestradiol increases expression ISO Naa15 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of NAA15 mRNA CTD PMID:17942748 Naa15 Rat 17alpha-ethynylestradiol multiple interactions ISO Naa15 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NAA15 mRNA CTD PMID:17942748 Naa15 Rat 17beta-estradiol increases expression ISO NAA15 (Homo sapiens) 6480464 Estradiol results in increased expression of NAA15 mRNA CTD PMID:23019147 and PMID:31614463 Naa15 Rat 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO NAA15 (Homo sapiens) 6480464 Metribolone results in increased expression of NAA15 mRNA CTD PMID:17010196 Naa15 Rat 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO NAA15 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 Naa15 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Naa15 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of NAA15 mRNA and [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NAA15 mRNA CTD PMID:17942748 and PMID:19465110 Naa15 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NAA15 mRNA CTD PMID:20959002 and PMID:32109520 Naa15 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Naa15 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of NAA15 mRNA CTD PMID:19770486 and PMID:20159946 Naa15 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Naa15 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of NAA15 mRNA CTD PMID:21570461 Naa15 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of NAA15 mRNA CTD PMID:21346803 Naa15 Rat 2,6-dimethoxyphenol multiple interactions ISO NAA15 (Homo sapiens) 6480464 [Furaldehyde co-treated with pyrogallol 1 more ... CTD PMID:38598786 Naa15 Rat 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of NAA15 mRNA CTD PMID:21346803 Naa15 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO NAA15 (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of NAA15 protein CTD PMID:31675489 Naa15 Rat 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of NAA15 protein CTD PMID:34915118 Naa15 Rat 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of NAA15 mRNA CTD PMID:19162173 Naa15 Rat 4,4'-sulfonyldiphenol increases expression ISO Naa15 (Mus musculus) 6480464 bisphenol S results in increased expression of NAA15 mRNA CTD PMID:39298647 Naa15 Rat 4,4'-sulfonyldiphenol decreases methylation ISO NAA15 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of NAA15 gene CTD PMID:31601247 Naa15 Rat 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of NAA15 mRNA CTD PMID:21346803 Naa15 Rat acetazolamide increases expression ISO Naa15 (Mus musculus) 6480464 Acetazolamide results in increased expression of NAA15 mRNA CTD PMID:19274763 Naa15 Rat acetylsalicylic acid decreases expression EXP 6480464 Aspirin results in decreased expression of NAA15 mRNA CTD PMID:12800193 Naa15 Rat aflatoxin B1 increases expression ISO Naa15 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of NAA15 mRNA CTD PMID:19770486 Naa15 Rat aflatoxin B1 decreases methylation ISO NAA15 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of NAA15 gene CTD PMID:27153756 Naa15 Rat aflatoxin M1 decreases expression ISO NAA15 (Homo sapiens) 6480464 Aflatoxin M1 results in decreased expression of NAA15 mRNA CTD PMID:30928695 Naa15 Rat all-trans-retinoic acid decreases expression ISO NAA15 (Homo sapiens) 6480464 Tretinoin results in decreased expression of NAA15 mRNA and Tretinoin results in decreased expression of NAA15 protein CTD PMID:16638120 and PMID:33167477 Naa15 Rat aristolochic acid A decreases expression ISO NAA15 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of NAA15 mRNA CTD PMID:33212167 Naa15 Rat atrazine decreases expression ISO NAA15 (Homo sapiens) 6480464 Atrazine results in decreased expression of NAA15 mRNA CTD PMID:22378314 Naa15 Rat benzo[a]pyrene decreases expression ISO Naa15 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of NAA15 mRNA CTD PMID:19770486 Naa15 Rat benzo[a]pyrene diol epoxide I increases expression ISO NAA15 (Homo sapiens) 6480464 7 more ... CTD PMID:20018196 Naa15 Rat benzo[a]pyrene diol epoxide I decreases expression ISO NAA15 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 Naa15 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NAA15 mRNA CTD PMID:25181051 and PMID:34947998 Naa15 Rat bisphenol A decreases expression ISO NAA15 (Homo sapiens) 6480464 bisphenol A results in decreased expression of NAA15 protein CTD PMID:31675489 Naa15 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of NAA15 gene CTD PMID:28505145 Naa15 Rat bisphenol AF increases expression ISO NAA15 (Homo sapiens) 6480464 bisphenol AF results in increased expression of NAA15 protein CTD PMID:34186270 Naa15 Rat Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of NAA15 protein CTD PMID:28903499 Naa15 Rat buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of NAA15 mRNA CTD PMID:24136188 Naa15 Rat butyric acid decreases expression EXP 6480464 Butyric Acid results in decreased expression of NAA15 mRNA CTD PMID:12800193 Naa15 Rat cadmium dichloride increases expression ISO NAA15 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of NAA15 mRNA CTD PMID:26472689 Naa15 Rat carbon nanotube increases expression ISO Naa15 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of NAA15 mRNA CTD PMID:25554681 Naa15 Rat CGP 52608 multiple interactions ISO NAA15 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to NAA15 gene] CTD PMID:28238834 Naa15 Rat chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of NAA15 mRNA CTD PMID:23125180 Naa15 Rat chlorpyrifos decreases expression ISO Naa15 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of NAA15 mRNA CTD PMID:37019170 Naa15 Rat chromium(6+) affects expression ISO Naa15 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of NAA15 mRNA CTD PMID:28472532 Naa15 Rat cisplatin multiple interactions ISO NAA15 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of NAA15 mRNA CTD PMID:27392435 Naa15 Rat cisplatin decreases expression ISO NAA15 (Homo sapiens) 6480464 Cisplatin results in decreased expression of NAA15 mRNA CTD PMID:27392435 Naa15 Rat cocaine increases expression EXP 6480464 Cocaine results in increased expression of NAA15 mRNA CTD PMID:17898221 Naa15 Rat copper atom multiple interactions ISO NAA15 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of NAA15 mRNA CTD PMID:20971185 Naa15 Rat copper(0) multiple interactions ISO NAA15 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of NAA15 mRNA CTD PMID:20971185 Naa15 Rat copper(II) sulfate increases expression ISO NAA15 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of NAA15 mRNA CTD PMID:19549813 Naa15 Rat coumestrol increases expression ISO NAA15 (Homo sapiens) 6480464 Coumestrol results in increased expression of NAA15 mRNA CTD PMID:19167446 Naa15 Rat crocidolite asbestos affects expression ISO NAA15 (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of NAA15 mRNA CTD PMID:17331233 Naa15 Rat cyclosporin A increases expression ISO NAA15 (Homo sapiens) 6480464 Cyclosporine results in increased expression of NAA15 mRNA CTD PMID:25562108 Naa15 Rat DDE increases expression ISO NAA15 (Homo sapiens) 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of NAA15 mRNA CTD PMID:38568856 Naa15 Rat doxorubicin decreases expression ISO NAA15 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of NAA15 mRNA CTD PMID:29803840 Naa15 Rat enzyme inhibitor multiple interactions ISO NAA15 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NAA15 protein CTD PMID:23301498 Naa15 Rat ethyl methanesulfonate decreases expression ISO NAA15 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of NAA15 mRNA CTD PMID:23649840 Naa15 Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of NAA15 mRNA CTD PMID:24136188 Naa15 Rat folic acid multiple interactions ISO Naa15 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of NAA15 mRNA CTD PMID:22206623 Naa15 Rat formaldehyde decreases expression ISO NAA15 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of NAA15 mRNA CTD PMID:23649840 Naa15 Rat FR900359 increases phosphorylation ISO NAA15 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of NAA15 protein CTD PMID:37730182 Naa15 Rat furfural multiple interactions ISO NAA15 (Homo sapiens) 6480464 [Furaldehyde co-treated with pyrogallol 1 more ... CTD PMID:38598786 Naa15 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of NAA15 mRNA CTD PMID:22061828 and PMID:33387578 Naa15 Rat hydrogen cyanide increases expression ISO Naa15 (Mus musculus) 6480464 Hydrogen Cyanide results in increased expression of NAA15 mRNA CTD PMID:33914522 Naa15 Rat hypochlorous acid increases expression ISO Naa15 (Mus musculus) 6480464 Hypochlorous Acid results in increased expression of NAA15 mRNA CTD PMID:19376150 Naa15 Rat ivermectin decreases expression ISO NAA15 (Homo sapiens) 6480464 Ivermectin results in decreased expression of NAA15 protein CTD PMID:32959892 Naa15 Rat lead(0) increases expression ISO NAA15 (Homo sapiens) 6480464 Lead results in increased expression of NAA15 mRNA CTD PMID:19921347 Naa15 Rat methyl methanesulfonate decreases expression ISO NAA15 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of NAA15 mRNA CTD PMID:23649840 Naa15 Rat miconazole decreases expression ISO Naa15 (Mus musculus) 6480464 Miconazole results in decreased expression of NAA15 mRNA CTD PMID:27462272 Naa15 Rat nefazodone increases expression EXP 6480464 nefazodone results in increased expression of NAA15 mRNA CTD PMID:24136188 Naa15 Rat nickel atom increases expression ISO NAA15 (Homo sapiens) 6480464 Nickel results in increased expression of NAA15 mRNA CTD PMID:24768652 and PMID:25583101 Naa15 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NAA15 mRNA CTD PMID:25729387 Naa15 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of NAA15 mRNA CTD PMID:33387578 Naa15 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Naa15 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of NAA15 mRNA CTD PMID:36331819 Naa15 Rat perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of NAA15 mRNA CTD PMID:19162173 Naa15 Rat phenobarbital decreases expression ISO Naa15 (Mus musculus) 6480464 Phenobarbital results in decreased expression of NAA15 mRNA CTD PMID:23091169 Naa15 Rat phosgene affects expression ISO Naa15 (Mus musculus) 6480464 Phosgene affects the expression of NAA15 mRNA CTD PMID:16300373 Naa15 Rat piroxicam increases expression ISO NAA15 (Homo sapiens) 6480464 Piroxicam results in increased expression of NAA15 mRNA CTD PMID:21858171 Naa15 Rat potassium chromate multiple interactions ISO NAA15 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NAA15 mRNA CTD PMID:22079256 Naa15 Rat potassium chromate decreases expression ISO NAA15 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of NAA15 mRNA CTD PMID:22079256 Naa15 Rat potassium cyanide increases expression ISO Naa15 (Mus musculus) 6480464 Potassium Cyanide results in increased expression of NAA15 mRNA CTD PMID:33914522 Naa15 Rat quercetin decreases expression ISO NAA15 (Homo sapiens) 6480464 Quercetin results in decreased expression of NAA15 protein CTD PMID:15221776 Naa15 Rat quercetin increases expression ISO NAA15 (Homo sapiens) 6480464 Quercetin results in increased expression of NAA15 protein CTD PMID:14750173 Naa15 Rat resveratrol multiple interactions ISO NAA15 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of NAA15 mRNA CTD PMID:23557933 Naa15 Rat SB 431542 multiple interactions ISO NAA15 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NAA15 protein CTD PMID:37664457 Naa15 Rat sodium arsenate increases expression ISO Naa15 (Mus musculus) 6480464 sodium arsenate results in increased expression of NAA15 mRNA CTD PMID:21795629 Naa15 Rat sodium arsenite decreases expression ISO NAA15 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of NAA15 mRNA CTD PMID:38568856 Naa15 Rat sodium arsenite multiple interactions ISO NAA15 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of and results in increased activity of NAA15 protein CTD PMID:30528433 Naa15 Rat sodium chloride multiple interactions ISO NAA15 (Homo sapiens) 6480464 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of NAA15 protein more ... CTD PMID:38598786 Naa15 Rat tert-butyl hydroperoxide increases expression ISO NAA15 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of NAA15 mRNA CTD PMID:15336504 Naa15 Rat testosterone enanthate affects expression ISO NAA15 (Homo sapiens) 6480464 testosterone enanthate affects the expression of NAA15 mRNA CTD PMID:17440010 Naa15 Rat tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of NAA15 mRNA CTD PMID:31150632 Naa15 Rat tetrachloromethane increases expression ISO Naa15 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of NAA15 mRNA CTD PMID:31919559 Naa15 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of NAA15 mRNA CTD PMID:23411599 and PMID:34492290 Naa15 Rat titanium dioxide decreases methylation ISO Naa15 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of NAA15 gene CTD PMID:35295148 Naa15 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NAA15 mRNA CTD PMID:25729387 Naa15 Rat torcetrapib increases expression ISO NAA15 (Homo sapiens) 6480464 torcetrapib results in increased expression of NAA15 mRNA CTD PMID:23228038 Naa15 Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of NAA15 mRNA CTD PMID:33387578 Naa15 Rat trimellitic anhydride increases expression ISO Naa15 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of NAA15 mRNA CTD PMID:19042947 Naa15 Rat triphenyl phosphate affects expression ISO NAA15 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of NAA15 mRNA CTD PMID:37042841 Naa15 Rat triptonide increases expression ISO Naa15 (Mus musculus) 6480464 triptonide results in increased expression of NAA15 mRNA CTD PMID:33045310 Naa15 Rat trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of NAA15 mRNA CTD PMID:24136188 Naa15 Rat tungsten decreases expression ISO Naa15 (Mus musculus) 6480464 Tungsten results in decreased expression of NAA15 mRNA CTD PMID:30912803 Naa15 Rat urethane decreases expression ISO NAA15 (Homo sapiens) 6480464 Urethane results in decreased expression of NAA15 mRNA CTD PMID:28818685 Naa15 Rat valproic acid affects expression ISO Naa15 (Mus musculus) 6480464 Valproic Acid affects the expression of NAA15 mRNA CTD PMID:17292431 Naa15 Rat valproic acid increases expression ISO NAA15 (Homo sapiens) 6480464 Valproic Acid results in increased expression of NAA15 mRNA CTD PMID:23179753 Naa15 Rat valproic acid affects expression ISO NAA15 (Homo sapiens) 6480464 Valproic Acid affects the expression of NAA15 mRNA CTD PMID:25979313 Naa15 Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of NAA15 mRNA CTD PMID:19015723 Naa15 Rat vitamin E decreases expression ISO NAA15 (Homo sapiens) 6480464 Vitamin E results in decreased expression of NAA15 mRNA CTD PMID:19244175
(-)-epigallocatechin 3-gallate (ISO) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (ISO) 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one (ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dinitrotoluene (EXP) 2,6-dimethoxyphenol (ISO) 2,6-dinitrotoluene (EXP) 3,3',5,5'-tetrabromobisphenol A (ISO) 3-chloropropane-1,2-diol (EXP) 3H-1,2-dithiole-3-thione (EXP) 4,4'-sulfonyldiphenol (ISO) 4-amino-2,6-dinitrotoluene (EXP) acetazolamide (ISO) acetylsalicylic acid (EXP) aflatoxin B1 (ISO) aflatoxin M1 (ISO) all-trans-retinoic acid (ISO) aristolochic acid A (ISO) atrazine (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) bisphenol A (EXP,ISO) bisphenol AF (ISO) Brodifacoum (EXP) buspirone (EXP) butyric acid (EXP) cadmium dichloride (ISO) carbon nanotube (ISO) CGP 52608 (ISO) chloroprene (EXP) chlorpyrifos (ISO) chromium(6+) (ISO) cisplatin (ISO) cocaine (EXP) copper atom (ISO) copper(0) (ISO) copper(II) sulfate (ISO) coumestrol (ISO) crocidolite asbestos (ISO) cyclosporin A (ISO) DDE (ISO) doxorubicin (ISO) enzyme inhibitor (ISO) ethyl methanesulfonate (ISO) flutamide (EXP) folic acid (ISO) formaldehyde (ISO) FR900359 (ISO) furfural (ISO) gentamycin (EXP) hydrogen cyanide (ISO) hypochlorous acid (ISO) ivermectin (ISO) lead(0) (ISO) methyl methanesulfonate (ISO) miconazole (ISO) nefazodone (EXP) nickel atom (ISO) oxaliplatin (EXP) paracetamol (EXP) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (EXP) phenobarbital (ISO) phosgene (ISO) piroxicam (ISO) potassium chromate (ISO) potassium cyanide (ISO) quercetin (ISO) resveratrol (ISO) SB 431542 (ISO) sodium arsenate (ISO) sodium arsenite (ISO) sodium chloride (ISO) tert-butyl hydroperoxide (ISO) testosterone enanthate (ISO) tetrachloromethane (EXP,ISO) thioacetamide (EXP) titanium dioxide (ISO) topotecan (EXP) torcetrapib (ISO) trichloroethene (EXP) trimellitic anhydride (ISO) triphenyl phosphate (ISO) triptonide (ISO) trovafloxacin (EXP) tungsten (ISO) urethane (ISO) valproic acid (ISO) vinclozolin (EXP) vitamin E (ISO)
Naa15 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 2 137,608,883 - 137,671,618 (+) NCBI GRCr8 mRatBN7.2 2 135,458,018 - 135,520,756 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 2 135,457,948 - 135,520,756 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 2 142,033,903 - 142,096,632 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 2 140,146,168 - 140,208,898 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 2 134,777,618 - 134,840,821 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 2 140,471,437 - 140,534,259 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 140,471,690 - 140,534,259 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 2 159,946,628 - 160,009,197 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 2 140,308,955 - 140,371,869 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 2 140,258,958 - 140,319,864 (+) NCBI Celera 2 129,953,617 - 130,016,267 (+) NCBI Celera Cytogenetic Map 2 q26 NCBI
NAA15 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 4 139,301,505 - 139,391,384 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 4 139,301,446 - 139,420,033 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 4 140,222,659 - 140,312,538 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 4 140,442,126 - 140,531,385 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 4 140,580,280 - 140,669,540 NCBI Celera 4 137,554,846 - 137,644,102 (+) NCBI Celera Cytogenetic Map 4 q31.1 NCBI HuRef 4 135,952,782 - 136,041,659 (+) NCBI HuRef CHM1_1 4 140,199,902 - 140,289,175 (+) NCBI CHM1_1 T2T-CHM13v2.0 4 142,621,100 - 142,711,046 (+) NCBI T2T-CHM13v2.0
Naa15 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 3 51,323,437 - 51,383,406 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 3 51,322,569 - 51,383,928 (+) Ensembl GRCm39 Ensembl GRCm38 3 51,416,016 - 51,475,985 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 3 51,415,148 - 51,476,507 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 3 51,219,938 - 51,279,907 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 3 51,504,058 - 51,561,960 (+) NCBI MGSCv36 mm8 Celera 3 51,143,148 - 51,206,944 (+) NCBI Celera Cytogenetic Map 3 C NCBI cM Map 3 22.47 NCBI
Naa15 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955428 4,243,970 - 4,337,356 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955428 4,243,970 - 4,337,357 (-) NCBI ChiLan1.0 ChiLan1.0
NAA15 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 3 137,176,378 - 137,264,745 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 4 137,568,750 - 137,657,036 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 4 131,666,703 - 131,755,026 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 4 142,975,740 - 143,064,311 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 4 142,975,740 - 143,064,311 (+) Ensembl panpan1.1 panPan2
NAA15 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 19 3,307,929 - 3,366,189 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 19 3,309,259 - 3,362,059 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 19 3,557,057 - 3,640,935 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 19 3,379,499 - 3,463,413 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 19 3,381,180 - 3,463,406 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 19 3,310,989 - 3,394,856 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 19 3,672,630 - 3,756,470 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 19 4,036,375 - 4,120,241 (-) NCBI UU_Cfam_GSD_1.0
Naa15 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405301 50,781,253 - 50,864,090 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936535 8,217,578 - 8,301,497 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936535 8,219,764 - 8,301,425 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
NAA15 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 8 87,608,426 - 87,691,236 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 8 87,608,439 - 87,691,313 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 8 93,187,888 - 93,401,708 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
NAA15 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 7 86,266,663 - 86,358,340 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 7 86,269,166 - 86,355,777 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666037 65,789,762 - 65,880,617 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Naa15 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 1571 Count of miRNA genes: 367 Interacting mature miRNAs: 536 Transcripts: ENSRNOT00000017379 Prediction methods: Microtar, Miranda, Targetscan Result types: miRGate_prediction
1578648 Bss11 Bone structure and strength QTL 11 4.7 femur morphology trait (VT:0000559) femoral neck cortical cross-sectional area (CMO:0001702) 2 114837527 211674221 Rat 2293671 Bss44 Bone structure and strength QTL 44 10.97 0.0001 lumbar vertebra morphology trait (VT:0010494) lumbar vertebra cortical cross-sectional area (CMO:0001690) 2 43162366 148478373 Rat 631566 Bp90 Blood pressure QTL 90 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 102803808 147803808 Rat 1298074 Bp164 Blood pressure QTL 164 0.003 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 42804607 202447032 Rat 6907363 Bp357 Blood pressure QTL 357 4.1 0.002 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 129540907 174540907 Rat 1354648 Bp239 Blood pressure QTL 239 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 66118463 226797303 Rat 1358360 Sradr2 Stress Responsive Adrenal Weight QTL 2 10.24 adrenal gland mass (VT:0010420) both adrenal glands wet weight (CMO:0000164) 2 129164097 152195315 Rat 1354649 Kidm17 Kidney mass QTL 17 2.9 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 2 81754530 227146641 Rat 10755499 Bp389 Blood pressure QTL 389 2.61 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 18960362 228801039 Rat 152025245 Scl81 Serum cholesterol level QTL 81 3.49 blood cholesterol amount (VT:0000180) 2 122609194 206936711 Rat 1581578 Cm49 Cardiac mass QTL 49 4.9 0.01 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 2 127447387 143657569 Rat 1598862 Glom9 Glomerulus QTL 9 3.5 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 2 92337601 137337601 Rat 631198 Cm22 Cardiac mass QTL 22 4.3 0.0008 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 2 76539322 150540526 Rat 1598863 Cm65 Cardiac mass QTL 65 2.3 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 92337601 137337601 Rat 1554319 Bmd2 Bone mineral density QTL 2 13.4 0.0001 lumbar vertebra area (VT:0010570) lumbar vertebra cross-sectional area (CMO:0001689) 2 114837675 212549332 Rat 1302794 Stl27 Serum triglyceride level QTL 27 4.4 0.0001 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 2 25413423 143657569 Rat 1581569 Uae32 Urinary albumin excretion QTL 32 0.0001 urine protein amount (VT:0005160) urine albumin excretion rate (CMO:0000757) 2 78665619 219826953 Rat 61467 Bp14 Blood pressure QTL 14 2.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 43154682 202446871 Rat 1358901 Cm38 Cardiac mass QTL 38 2 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 157142209 Rat 1359030 Bp277 Blood pressure QTL 277 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 114837527 185876470 Rat 1331760 Bp206 Blood pressure QTL 206 3.62454 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 56043031 202447032 Rat 1358899 Kidm23 Kidney mass QTL 23 3.88 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1358908 Bw49 Body weight QTL 49 3.36 body mass (VT:0001259) body weight (CMO:0000012) 2 25413652 157142078 Rat 1582257 Gluco21 Glucose level QTL 21 3.1 0.0035 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 2 118111229 157142209 Rat 1358910 Kidm27 Kidney mass QTL 27 5.77 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1358911 Kidm28 Kidney mass QTL 28 5.42 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1358904 Cm39 Cardiac mass QTL 39 2.26 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 157142209 Rat 1359035 Bp276 Blood pressure QTL 276 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 114837527 143657569 Rat 8662836 Vetf8 Vascular elastic tissue fragility QTL 8 0.66 thoracic aorta molecular composition trait (VT:0010568) aorta wall extracellular elastin dry weight to aorta wall extracellular collagen weight ratio (CMO:0002003) 2 104559726 149559726 Rat 1358887 Bw50 Body weight QTL 50 2.39 body mass (VT:0001259) body weight (CMO:0000012) 2 25413652 157142078 Rat 1298080 Bp163 Blood pressure QTL 163 0.02 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 66118275 202447032 Rat 8662832 Vetf7 Vascular elastic tissue fragility QTL 7 3.5 aorta elastin amount (VT:0003905) aorta wall extracellular elastin dry weight to aorta wall dry weight ratio (CMO:0002002) 2 81689826 221035911 Rat 5135226 Leukc2 Leukocyte quantity QTL 2 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 2 118111229 149559726 Rat 1298085 Bp165 Blood pressure QTL 165 0.0006 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 42804607 202447032 Rat 2290453 Scl55 Serum cholesterol level QTL 55 2.83 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 2 26917817 136917119 Rat 2299162 Iddm32 Insulin dependent diabetes mellitus QTL 32 2.36 blood glucose amount (VT:0000188) age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) 2 78665616 143657569 Rat 1358894 Kidm24 Kidney mass QTL 24 4.03 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 724534 Uae6 Urinary albumin excretion QTL 6 10 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 2 78665619 249053267 Rat 61374 Edpm2 Estrogen-dependent pituitary mass QTL 2 4.42 0.86 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 2 76539322 202447032 Rat 634308 Sach6 Saccharin preference QTL 6 4.9 taste sensitivity trait (VT:0001986) saccharin intake volume to total fluid intake volume ratio (CMO:0001601) 2 112456140 212696837 Rat 1358917 Cm42 Cardiac mass QTL 42 2.82 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 203928301 Rat 1358913 Cm41 Cardiac mass QTL 41 2.73 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 203928301 Rat 1300165 Rf9 Renal function QTL 9 3.28 kidney glomerulus integrity trait (VT:0010546) index of glomerular damage (CMO:0001135) 2 133914684 202447032 Rat 631507 Bp105 Blood pressure QTL 105 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 112456140 212696837 Rat 738007 Anxrr7 Anxiety related response QTL 7 4.4 exploratory behavior trait (VT:0010471) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 2 118189491 163189491 Rat 2293835 Kiddil5 Kidney dilation QTL 5 3.8 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 2 42804607 157142209 Rat 1581552 Pur12 Proteinuria QTL 12 5.19 0.0009 urine total protein amount (VT:0000032) urine protein excretion rate (CMO:0000759) 2 112103657 148076632 Rat 1558653 Prcr1 Prostate cancer resistance QTL 1 5 prostate integrity trait (VT:0010571) area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio (CMO:0000899) 2 72532993 157142209 Rat 1354622 Kidm16 Kidney mass QTL 16 3 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 2 81754530 222436696 Rat 631266 Bp132 Blood pressure QTL 132 0.0005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 46123260 202447032 Rat 2293843 Kiddil6 Kidney dilation QTL 6 3.1 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 2 42804607 182042367 Rat 1354594 Despr10 Despair related QTL 10 2e-06 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 2 114654253 159654253 Rat 152025206 Hrtrt23 Heart rate QTL 23 5.98 heart pumping trait (VT:2000009) 2 28484589 169504100 Rat 1354605 Rf48 Renal function QTL 48 2.9 blood creatinine amount (VT:0005328) plasma creatinine level (CMO:0000537) 2 74786664 206665859 Rat 152025204 Hrtrt22 Heart rate QTL 22 5.6 heart pumping trait (VT:2000009) 2 28484589 169504100 Rat 1354601 Slep1 Serum leptin concentration QTL 1 5.39 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 2 43171017 184114403 Rat 61438 Cia7 Collagen induced arthritis QTL 7 4.6 0.0001 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 2 59324377 141596857 Rat
RH138227
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 135,519,509 - 135,519,676 (+) MAPPER mRatBN7.2 Rnor_6.0 2 140,533,013 - 140,533,179 NCBI Rnor6.0 Rnor_5.0 2 160,007,951 - 160,008,117 UniSTS Rnor5.0 RGSC_v3.4 2 140,370,623 - 140,370,789 UniSTS RGSC3.4 Celera 2 130,015,021 - 130,015,187 UniSTS RH 3.4 Map 2 859.8 UniSTS Cytogenetic Map 2 q26 UniSTS
RH133610
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 135,519,826 - 135,520,022 (+) MAPPER mRatBN7.2 Rnor_6.0 2 140,533,330 - 140,533,525 NCBI Rnor6.0 Rnor_5.0 2 160,008,268 - 160,008,463 UniSTS Rnor5.0 RGSC_v3.4 2 140,370,940 - 140,371,135 UniSTS RGSC3.4 Celera 2 130,015,338 - 130,015,533 UniSTS RH 3.4 Map 2 858.2 UniSTS Cytogenetic Map 2 q26 UniSTS
MARC_15315-15316:1013436374:1
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 135,517,549 - 135,518,010 (+) MAPPER mRatBN7.2 Rnor_6.0 2 140,531,053 - 140,531,513 NCBI Rnor6.0 Rnor_5.0 2 160,005,991 - 160,006,451 UniSTS Rnor5.0 RGSC_v3.4 2 140,368,663 - 140,369,123 UniSTS RGSC3.4 Celera 2 130,013,061 - 130,013,521 UniSTS Cytogenetic Map 2 q26 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000017379 ⟹ ENSRNOP00000017379
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 2 135,458,018 - 135,520,756 (+) Ensembl Rnor_6.0 Ensembl 2 140,471,690 - 140,534,259 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000095909 ⟹ ENSRNOP00000084362
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 2 135,480,083 - 135,520,756 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000120176 ⟹ ENSRNOP00000086714
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 2 135,457,948 - 135,518,781 (+) Ensembl
RefSeq Acc Id:
NM_001107674 ⟹ NP_001101144
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 137,608,883 - 137,671,618 (+) NCBI mRatBN7.2 2 135,458,018 - 135,520,756 (+) NCBI Rnor_6.0 2 140,471,690 - 140,534,259 (+) NCBI Rnor_5.0 2 159,946,628 - 160,009,197 (+) NCBI RGSC_v3.4 2 140,308,955 - 140,371,869 (+) RGD Celera 2 129,953,617 - 130,016,267 (+) RGD
Sequence:
CGTGAGGGGGGAGGTGGCGGCAGCGTTAAGTGAGAAAGGGGGAAAAGGAGGAAAAAAAAAAGGAGGGGAAGGGAGTGTCAGGACAGGGTGGTGCGGCGACACGGGAGGCCTAGTGGCGGCAGAGTGGA GGTTTCAAGGCTGAAGTGAGCTCGGAAACGGCAGTGGCGGCGGGCGGACAAACGGACTGACCGAGCCGGGTGGTGGCGGGAGCCGCGGGAGGAGCCGGAACCATGCCGGCCGTGAGCCTCCCGCCCAA GGAGAACGCGCTCTTCAAGAGGATCTTGAGATGTTATGAACATAAACAGTATAGAAATGGATTGAAGTTCTGTAAACAAATCCTTTCCAATCCCAAATTTGCAGAGCATGGAGAAACCCTGGCCATGA AAGGATTAACGTTGAACTGTTTGGGAAAAAAGGAAGAAGCTTATGAATTGGTTCGCAGAGGTTTGAGAAATGATTTAAAGAGTCATGTGTGTTGGCATGTTTATGGCCTTCTTCAGAGGTCAGACAAG AAGTATGATGAAGCCATTAAGTGCTACCGAAATGCACTGAAATGGGATAAAGACAATCTTCAGATCTTAAGAGATCTCTCCTTACTACAGATTCAAATGCGAGACCTTGAGGGCTATAGGGAAACAAG ATACCAGTTGCTTCAGCTTCGACCTGCACAGAGAGCATCATGGATTGGTTATGCTATTGCTTACCATTTATTAGAAGACTATGAAATGGCAGCAAAAATTTTAGAAGAGTTTAGGAAAACACAGCAGA CATCTCCTGATAAAGTGGATTATGAATATAGTGAACTCCTTTTATATCAGAATCAAGTTCTTCGGGAAGCAGGTCTTTATAGAGAAGCCTTGGAACATCTTTGTACCTATGAAAAGCAGATTTGTGAT AAACTTGCCGTTGAAGAAACCAAAGGAGAGCTTCTGTTGCAGTTGTGTCGTTTGGAAGATGCTGCTGATGTTTATAGAGGATTACAAGAGAGGAATCCTGAAAATTGGGCCTATTACAAAGGCTTAGA AAAAGCACTCAAGCCAGCTAATATGTTAGAACGGCTAAAAATATATGAGGAGGCCTGGACTAAATTCCCTAGGGGACTTGTGCCAAGAAGACTGCCATTAAACTTTTTATCTGGAGAGAAGTTTAAGG AGTGCTTGGATAGGTTTCTAAGGATGAATTTCAGCAAGGGTTGTCCACCGGTCTTCAATACCTTGAGGTCTTTATACAGAGATAAAGAGAAGGTGGCAATTGTAGAAGAACTAGTAGTTGGTTATGAA ACTTCTCTAAAAAGCTGTCGCCTATTTAACCCCAATGATGATGGAAAGGAGGAACCTCCAACCACATTACTTTGGGTCCAGTACTATTTGGCACAGCATTATGATAAAATTGGCCAGCCATCTATTGC TCTGGAATACATAAATACCGCTATTGAAAGTACACCAACATTGATAGAACTCTTTCTTGTAAAAGCTAAAATCTATAAGCATGCTGGGAATATTAAAGAAGCTGCCAGGTGGATGGATGAAGCCCAGG CCCTGGACACAGCAGACAGATTTATTAATTCCAAGTGCGCAAAATACATGTTAAAAGCCAATCTGATTAAAGAGGCTGAAGAAATGTGTTCCAAGTTTACAAGGGAAGGAACATCAGCGGTAGAGAAC CTGAATGAGATGCAGTGTATGTGGTTCCAGACAGAATGTGCCCAGGCATACAAAGCAATGAACAAATTTGGTGAAGCACTTAAGAAATGCCACGAAATTGAGAGACATTTTATAGAAATCACCGATGA CCAGTTTGATTTTCATACATACTGTATGAGGAAGATCACCCTTAGATCATACGTGGACTTATTAAAACTAGAAGATGTACTTCGGCAGCATCCATTTTACTTCAAAGCAGCCAGAATTGCTATTGAGA TCTATCTGAAGCTGCATGACAACCCTCTCACAGACGAGAACAAAGAGCATGAGGCCGATACAGCAAACATGTCTGACAAAGAGTTAAAGAAACTACGTAATAAACAAAGAAGAGCTCAAAAGAAAGCC CAGATAGAAGAAGAGAAAAAAAATGCAGAAAAAGAAAAGCAGCAGCGAAATCAGAAAAAGAAAAAAGATGACGACGATGAGGAAATTGGAGGTCCCAAAGAAGAACTTATCCCTGAGAAATTGGCCAA GGTTGAAACTCCGTTGGAAGAAGCTATTAAGTTTTTAACACCATTGAAGAACTTGGTGAAGAACAAGATAGAAACTCATCTTTTTGCCTTTGAGATTTACTTTAGGAAAGAAAAGTTTCTTTTGATGC TACAATCAGTAAAGCGGGCGTTTGCTATTGATTCTAGTCATCCCTGGCTTCATGAATGCATGATTCGACTCTTTAATTCTGTGTGTGAAAGTAAAGACTTACCTGAAGCAGTTAGAACAGTATTAAAA CAAGAAATGAATCGTCTTTTTGGAGCAACAAATCCAAAGAATTTTAATGAAACCTTTCTGAAAAGGAATTCTGATTCATTGCCACATAGATTATCAGCTGCCAAAATGATATATTATTTAGATTCTTC TAGTCAGAAACGAGCAATAGAGCTGGCAACAACACTTGATGGATCCCTCACCAACAGAAACCTTCAGACGTGCATGGAGGTGTTGGAAGCCTTGTGTGGTGGTAGCTTAGGAGACTGTAAAGAAGCTG CTGAAGCGTATAGAGTGAGTTGTCATAAGCTTTTCCCTTATGCTCTGGCTTTCATGCCTCCTGGATATGAAGAGGATATGAAGATCACAGTTAACGGAGATAGTTCTGCAGAAACGGAAGAACTGGCC AATGAAATTTGAACATCATTAAACAAGCAAACGGAATGACTTTGGACCATATCTAGTGTATAATATTTTTGTCACGCACCTGCTGCATTGCTCTTACTTACACAGAATGAGAGGAGTAAATGTTCTTG CCTTCAAATAGTCTTACGTTTTTTTATCCTGCTGAAAACTATATATAAAATATCTTAACATTACAGGATATAGGTTCAGTTTCTTAAAAAATTAAAAGCTGCTAAAATTGAGGGGTTTAAAAGAAAAA AAAATCCGTATCCTATTCCTACCTTCCCTTCCCATGTTTTTAACTAATTTATATACTCTGGAGGCTATAACAGCTAACATAGCAGGTGTGTGGCAGAAATATTACTTTAAATTTGTCTTGTGAGATTT TACTATATCTCAGACAGCATAAATGCTGTTTTAGCACTGGATTCTTTCACTGAGCACAAAGAGTTGTTGGGGCTTTAGCATCTGACTGATTTTGTTACGGGGTTGATTATTGACCATAGGAAGTATGC AATGTGAATCACTGTGTACAGAGCCATCTACAACAGATGCTTGACGTTGTAGATAACTTGGACACATAGCTACCAAGCAGATTAAATGAAACCTAGAAGGTGTTCAGTACGTGTGTTGTGTTTCCAAA ATTCACTGTACATGATCAGTTTGGTGTTCTTGTACCACAGTTTTTAACCGAAGGAACCAGTTGGAACAATCTCAATTTAACTAAAACTTGAAGAACTAAAATAACAATGCAAAGCTTTAGCATTGTTT TGGCCAAACTTGTTAAAACTGTAATGCAAGAACCAAATGCACTGTGATGTGGCACCAACTAATTAGCAAGCATGACTTTTTCACCTGAGAGTGAAAAAAGGAAACTCTACCATGGCTTGAAGTTAAAG AGCAGAACTCCTGACTACCATTCTGATCAAGAGACTAATAGCTAAAAACCTCAGCAGGCCTTGTTCACGATATGCAGAAAAAGTGCTGCAGTTTAGATACCTCTGGAACTTTTCCACAGTGTCACAGG TTTGTAATACTTGAAGCCCTTCATTTCTAAGAATATATTTCTTGCTCAGTTGTTTCAGGCAAGCCCAAGACTTTGTAATTTTTAAAGGGCCCAAGATTTTTCTTTTCAATAACAGACCAGCTTCTTTT TCCTGCAGTTACAAATGTAATTTCTTTTTTGTTGTCAAACATAAGGTACCAAATATGATGCAATAAATTGTTTTGAAAAACAGTTGTGTGAATATTTCCACTAATCCGAGTTGGGCTTCTGTGAAATG CACAGGTGGAAACAGAGGTTGCAAGCCAGAGGCAATGAAATGCACTGTAGGGCTAGTATAGAGGGGAGCTTTTTAGAATGGGCTAAATGGTGGTGTCAGGGAAGTTCCAGAATTAAGTAGAATGCTGC TCCTTTGTTCAGATTTCACTGAGGGCTAGGATGGTGGCAGGTCCTATGAATGTAATTCATAATCTGAAAGGGAAACTAAACATGACCATTTTGATTGGGATAATGAGCCTTAAACATGTCAAACCTGG ACACTGAGAACTAGCCTCAGGCTCAATATTTCTTTATGTTTGCAAGGTCTGAGCAATTAAGTTTAAGTATAATGAATTAAGTGTATATAAAATTGAACTTTTGTAGTATTTTAGTTATAGATAGTACA TACACTAAAGGGAATTTTCAGAAGATGAGATCCATTTATTTCATAGTACATGATCTGCATTCCACGTCCCAGTCTAGCAGGTTAGTGATGCACAAGTACGTACAGTCTGAACTCCAGTGCTTTGCTTT AACAGGCCCTGTCTCAGGAACATCTTAACAGATGGCAAAAGAAAAGTGAGCAAACTTTAAAAATTTTTCTCCTATGAGTGGCAACTGAGGTTCCTTTTGTTTGGAAAGACACTAGTGGTATGTCCGCT ACTAATTCAGTGTTGGAGGAGGCACCAGCCATATAGTAGGTGTGCGTGTGTGGATTTGTTTAAATTCTACTGTATATCACAATGAAATCCGTCTGTTTGTCTTGACAATGTTTAAATGATATAGATTG TCTTAGGATGAATAACCAGAAATACTCAGAACTCTGATGCCGATGCCACCCGAGAGGAGCCAAATTCCTGTCGTGTATATTGTATTCCAACCAATTTTACTGGAACTATTGAATAAATCTTTTATTTT CTTTCAGGTTTATTTGATAGTGGATACATTGTCTGGTATCACAGGACCTTGACTGGGTTCACCTAAAACATTGTACTTTACTCTGAGCATATCTATCAATTGGATCATTTCACATTTACCCCATTCAT ATTGAGTTAATTTCCAGTGATACTGTGGGGGAAAACAGGGTTAGATAAACAAGTTGGAAAAATGCAGTGTGATGTTGTAATCTAAACAAGTGCCTTATGTTTATTGCTAAGAACTGGTGTTATCAACC CTTTTAATGAGAAGGGGTCCTCGGCCTGTATTAATATAGGAAAGTAAAGATCCTTCTGTTTTTCTTCATATTCACTCACTGTTATTTCTCATTGAAAAGCTAAAATCTGACTAGCTTAGTTTACTTAG CTTTAATTAGATAGGTGAGTCATACATTTTCACCCTTTTTTCTGTATTTATTATGCACAACAATAAAATGATCTCTAATAGCATGACGAAAAGTAGTGCCGATGTTGCTGGGAAGGTTTCTGGGTCTT ACTCGGCCCTGTGTTGTCACCATGATTGTACTGCATGCTCTATCCTGTCAGAGCTGTGAAATGAGAGCTGGGAATGTATGAAGAGCCATGGTCCAGGATCAGGTGGGTTGTGACGAACTCAAATCCTT TCTAATTAATTGGTAAGACTATTTCTGTTGCTGGGCATACCATCTATTTGGGGAAAGCTAAAAAGTAGAGTACTGAAAATACCAGGCATTTGTTATTTTAGATAACTACTGCCCCTGAATTCTGAAAA TGGCGATATTAAGAGAATTCAGATCAACCTTTCTGATGGAGGAAGTCTTCCCTTTCTGCATCATGTTCCTGGTTTTTACAGAGAAGGATTCTTCATACCATTTTGCTATTGTCTAAGCTTTGCTGAAC CCATTGTTAATCTAATACACAAACCCTATGAAATGGCTGGCTATGTTGTGCCATAGGAAGCAGAGATGGTCTCAGTTTTTGCTGGCTGAAAATTTAACAACTTGTAGCAATAAAACATTTTTGGAAAA GG
hide sequence
RefSeq Acc Id:
NP_001101144 ⟸ NM_001107674
- UniProtKB:
D3ZD89 (UniProtKB/TrEMBL), A6JV67 (UniProtKB/TrEMBL), A0A8I6A145 (UniProtKB/TrEMBL)
- Sequence:
MPAVSLPPKENALFKRILRCYEHKQYRNGLKFCKQILSNPKFAEHGETLAMKGLTLNCLGKKEEAYELVRRGLRNDLKSHVCWHVYGLLQRSDKKYDEAIKCYRNALKWDKDNLQILRDLSLLQIQMR DLEGYRETRYQLLQLRPAQRASWIGYAIAYHLLEDYEMAAKILEEFRKTQQTSPDKVDYEYSELLLYQNQVLREAGLYREALEHLCTYEKQICDKLAVEETKGELLLQLCRLEDAADVYRGLQERNPE NWAYYKGLEKALKPANMLERLKIYEEAWTKFPRGLVPRRLPLNFLSGEKFKECLDRFLRMNFSKGCPPVFNTLRSLYRDKEKVAIVEELVVGYETSLKSCRLFNPNDDGKEEPPTTLLWVQYYLAQHY DKIGQPSIALEYINTAIESTPTLIELFLVKAKIYKHAGNIKEAARWMDEAQALDTADRFINSKCAKYMLKANLIKEAEEMCSKFTREGTSAVENLNEMQCMWFQTECAQAYKAMNKFGEALKKCHEIE RHFIEITDDQFDFHTYCMRKITLRSYVDLLKLEDVLRQHPFYFKAARIAIEIYLKLHDNPLTDENKEHEADTANMSDKELKKLRNKQRRAQKKAQIEEEKKNAEKEKQQRNQKKKKDDDDEEIGGPKE ELIPEKLAKVETPLEEAIKFLTPLKNLVKNKIETHLFAFEIYFRKEKFLLMLQSVKRAFAIDSSHPWLHECMIRLFNSVCESKDLPEAVRTVLKQEMNRLFGATNPKNFNETFLKRNSDSLPHRLSAA KMIYYLDSSSQKRAIELATTLDGSLTNRNLQTCMEVLEALCGGSLGDCKEAAEAYRVSCHKLFPYALAFMPPGYEEDMKITVNGDSSAETEELANEI
hide sequence
Ensembl Acc Id:
ENSRNOP00000017379 ⟸ ENSRNOT00000017379
Ensembl Acc Id:
ENSRNOP00000084362 ⟸ ENSRNOT00000095909
Ensembl Acc Id:
ENSRNOP00000086714 ⟸ ENSRNOT00000120176
RGD ID: 13691318
Promoter ID: EPDNEW_R1843
Type: initiation region
Name: Naa15_1
Description: N-acetyltransferase 15, NatA auxiliary subunit
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 2 140,471,661 - 140,471,721 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2011-08-02
Naa15
N(alpha)-acetyltransferase 15, NatA auxiliary subunit
Narg1
NMDA receptor regulated 1
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-10-23
Narg1
NMDA receptor regulated 1
Narg1
NMDA receptor-regulated gene 1
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-04-30
Narg1
NMDA receptor-regulated gene 1
Narg1_predicted
NMDA receptor-regulated gene 1 (predicted)
'predicted' is removed
2292626
APPROVED
2005-01-12
Narg1_predicted
NMDA receptor-regulated gene 1 (predicted)
Symbol and Name status set to approved
70820
APPROVED